SG10201906475UA - Agent for improving early insulin secretory capacity - Google Patents

Agent for improving early insulin secretory capacity

Info

Publication number
SG10201906475UA
SG10201906475UA SG10201906475UA SG10201906475UA SG10201906475UA SG 10201906475U A SG10201906475U A SG 10201906475UA SG 10201906475U A SG10201906475U A SG 10201906475UA SG 10201906475U A SG10201906475U A SG 10201906475UA SG 10201906475U A SG10201906475U A SG 10201906475UA
Authority
SG
Singapore
Prior art keywords
agent
early insulin
secretory capacity
insulin secretory
improving early
Prior art date
Application number
SG10201906475UA
Inventor
Yasuto Yoshida
Eiichiro Naito
Satoru Kunihiro
Kouji Miyazaki
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Publication of SG10201906475UA publication Critical patent/SG10201906475UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

AGENT FOR IMPROVING EARLY INSULIN SECRETORY CAPACITY Provided is an early insulin secretion promoter. An early insulin secretion promoter having as an active ingredient a composition containing × 1010 cells or more of live lactic acid bacteria. -20-
SG10201906475UA 2015-01-22 2016-01-21 Agent for improving early insulin secretory capacity SG10201906475UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015010024 2015-01-22

Publications (1)

Publication Number Publication Date
SG10201906475UA true SG10201906475UA (en) 2019-08-27

Family

ID=56417184

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201705174WA SG11201705174WA (en) 2015-01-22 2016-01-21 Agent for improving early insulin secretory capacity
SG10201906475UA SG10201906475UA (en) 2015-01-22 2016-01-21 Agent for improving early insulin secretory capacity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201705174WA SG11201705174WA (en) 2015-01-22 2016-01-21 Agent for improving early insulin secretory capacity

Country Status (6)

Country Link
JP (1) JP6670256B2 (en)
KR (1) KR102497887B1 (en)
CN (1) CN107106619A (en)
MY (1) MY191218A (en)
SG (2) SG11201705174WA (en)
WO (1) WO2016117654A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190247450A1 (en) * 2016-10-28 2019-08-15 Kabushiki Kaisha Yakult Honsha Agent for inhibiting decrease in disease-free rate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0859492A (en) 1994-08-26 1996-03-05 Yakult Honsha Co Ltd Antidiabetic drug
JP2011193730A (en) * 2010-03-17 2011-10-06 Yakult Honsha Co Ltd Method for obtaining lactic acid bacterium having polysaccharide-peptidoglycan complex

Also Published As

Publication number Publication date
WO2016117654A1 (en) 2016-07-28
SG11201705174WA (en) 2017-07-28
CN107106619A (en) 2017-08-29
MY191218A (en) 2022-06-09
JPWO2016117654A1 (en) 2017-11-02
KR20170103774A (en) 2017-09-13
JP6670256B2 (en) 2020-03-18
KR102497887B1 (en) 2023-02-08

Similar Documents

Publication Publication Date Title
EP3269378A4 (en) Composition for preventing or treating inflammatory diseases, comprising lactic acid bacteria-derived extracellular vesicles as active ingredients
MX2017016819A (en) Antimicrobial compositions and uses thereof.
PH12017500361B1 (en) Novel compounds
MX2022001292A (en) Stereochemically enriched compositions for delivery of nucleic acids.
MX2023002516A (en) Bacterial compositions.
EP3659585A4 (en) Composition for delivering physiologically active ingredients into blood vessel
PH12017500416A1 (en) Compounds and compositions as raf kinase inhibitors
PH12017501019A1 (en) Isoxazole hydromaxamic acid compounds as lpxc inhibitors
NZ704125A (en) Bacillus megaterium bioactive compositions and metabolites
MX362349B (en) Minoxidil-containing hair growth composition.
KR102429539B9 (en) Composition for cryoprotecting lactic acid bacteria containing citrate
PH12017500708A1 (en) Probiotic and prebiotic compositions
MX2018003554A (en) Isoxazoline-substituted benzamides and analogues as insecticides.
MY192824A (en) Compound targeting il-23a and tnf-alpha and uses thereof
MX2016010451A (en) Microbiocidally active benzoxaboroles.
MX2015015162A (en) Uric acid level lowering agent.
MX2019011545A (en) Injectable cell and scaffold compositions.
MX2019010330A (en) Formulations with improved stability.
PH12017500357A1 (en) Lactic acid bacteria-containing composition
EP3313380A4 (en) Composition for delivery of active agents to an animal
EP4083187A4 (en) Lactic acid bacterium fermentation promoter
SG10201906475UA (en) Agent for improving early insulin secretory capacity
MX2015008373A (en) Antimicrobial peptides, compositions comprising the same and uses thereof.
MX2018000613A (en) Process for the preparation of a fermented milk product.
EP3047849A4 (en) Composition for promoting differentiation or proliferation of erythrocytic cells, containing monoacetyl diacylglycerol compound as active ingredient